| Interactions between Xenobiotics and DME (XEOTIC)
|
| Health or Environmental Toxicant(s) |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Benzo(a)pyrene |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen |
| DME Modulation |
Benzo(a)pyrene inhibits the expression of DME PRODH |
[1] |
| Ethyl methanesulfonate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00772
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen |
| DME Modulation |
Ethyl methanesulfonate up-regulates the expression of DME PRODH |
[2] |
| Natural Product(s), Extract(s) or Medicine(s) |
| Traditional Medicine |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Jinfukang |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00760
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Traditional Medicine |
| DME Modulation |
Jinfukang up-regulates the expression of DME PRODH |
[3] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 10 Xenobiotics
|
| Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Acetaminophen inhibits the expression of DME PRODH |
[4] |
| Calcitriol |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00184
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Calcitriol up-regulates the expression of DME PRODH |
[5] |
| Cisplatin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cisplatin up-regulates the expression of DME PRODH |
[3] |
| Copper sulfate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Copper sulfate up-regulates the expression of DME PRODH |
[6] |
| Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cyclosporine inhibits the expression of DME PRODH |
[1] |
| Diethylstilbestrol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00166
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Diethylstilbestrol inhibits the expression of DME PRODH |
[7] |
| Estradiol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00090
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Estradiol inhibits the expression of DME PRODH |
[8] |
| Fenofibrate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00035
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Fenofibrate inhibits the expression of DME PRODH |
[9] |
| Rosiglitazone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00380
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Rosiglitazone up-regulates the expression of DME PRODH |
[10] |
| Troglitazone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00086
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Troglitazone up-regulates the expression of DME PRODH and leads to increasing the drug-metabolizing activity of this enzyme |
[11] |
| Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Afimoxifene |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00610
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Afimoxifene inhibits the expression of DME PRODH |
[12] |
| Triclosan |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00560
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Triclosan inhibits the drug-metabolizing activity of DME PRODH |
[13] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| MS-275 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00581
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
MS-275 up-regulates the expression of DME PRODH |
[14] |
| Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Ciglitazone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00767
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Investigative Agent |
| DME Modulation |
Ciglitazone up-regulates the expression of DME PRODH |
[15] |
|
|
|
|
|
|